BHLHE41 and breast carcinoma: Recent evidence demonstrated that inhibition of DEC2 and nuclear receptor subfamily 2 group F member 1(NR2F1) resulted in increased growth of breast cancer cells [13] and downregulation of DEC2 interrupted tumor cell dormancy [14], indicating DEC2 might involve in tumor dormancy.